Potential radiation-sensitizing effect of semisynthetic epothilone B in human lung cancer cells.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000528:radiation effects; D018287:Carcinoma, Large Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D002453:Cell Cycle / Q000187:drug effects / Q000528:radiation effects; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D034261:Epothilones / Q000494:pharmacology*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007202:Indicators and Reagents; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D051379:Mice; D008819:Mice, Nude; D017239:Paclitaxel / Q000627:therapeutic use; D011419:Propidium; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D014183:Transplantation, Heterologous
D000970:Antineoplastic Agents; D034261:Epothilones; D007202:Indicators and Reagents; D011838:Radiation-Sensitizing Agents; D011419:Propidium; C430592:ixabepilone; D017239:Paclitaxel; C093788:epothilone B